
Cervical Health & HPV Study
This survey will take no longer than 5 minutes (12 questions) to complete and is intended to assess your eligibility for the KGK Science Clinical Trial. This clinical trial will investigate the safety and efficacy of Papillex on the regression of abnormal cervical cells caused by HPV. By pressing start, you are consenting to KGK Science asking you questions related to lifestyle and medical history regarding this study. All information collected will be kept in accordance with our Privacy Policy. https://kgkscience.com/about/privacy/
HIPAA
Compliance